BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30037822)

  • 1. Hip to the Game: YAP/TAZ is required for nonmelanoma skin cancers.
    Miranda MM; Lowry WE
    EMBO J; 2018 Sep; 37(17):. PubMed ID: 30037822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. YAP and TAZ are essential for basal and squamous cell carcinoma initiation.
    Debaugnies M; Sánchez-Danés A; Rorive S; Raphaël M; Liagre M; Parent MA; Brisebarre A; Salmon I; Blanpain C
    EMBO Rep; 2018 Jul; 19(7):. PubMed ID: 29875149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role.
    Van Haele M; Moya IM; Karaman R; Rens G; Snoeck J; Govaere O; Nevens F; Verslype C; Topal B; Monbaliu D; Halder G; Roskams T
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30717258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ.
    Kim M; Kim T; Johnson RL; Lim DS
    Cell Rep; 2015 Apr; 11(2):270-82. PubMed ID: 25843714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue inhibitor of metalloproteinase-1 promotes cell proliferation through YAP/TAZ activation in cancer.
    Ando T; Charindra D; Shrestha M; Umehara H; Ogawa I; Miyauchi M; Takata T
    Oncogene; 2018 Jan; 37(2):263-270. PubMed ID: 28925394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1.
    Hansen CG; Ng YL; Lam WL; Plouffe SW; Guan KL
    Cell Res; 2015 Dec; 25(12):1299-313. PubMed ID: 26611634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ.
    Zhang Z; Du J; Wang S; Shao L; Jin K; Li F; Wei B; Ding W; Fu P; van Dam H; Wang A; Jin J; Ding C; Yang B; Zheng M; Feng XH; Guan KL; Zhang L
    Mol Cell; 2019 Jan; 73(1):7-21.e7. PubMed ID: 30472188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p63 expression in normal skin and usual cutaneous carcinomas.
    Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
    J Cutan Pathol; 2002 Oct; 29(9):517-23. PubMed ID: 12358808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis.
    Lamar JM; Xiao Y; Norton E; Jiang ZG; Gerhard GM; Kooner S; Warren JSA; Hynes RO
    J Biol Chem; 2019 Feb; 294(7):2302-2317. PubMed ID: 30559289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells.
    Li Y; Kong F; Wang J; Hu E; Wang R; Liu J; Xiao Q; Zhang W; He D; Xiao X
    Oncotarget; 2016 Jun; 7(25):38133-38142. PubMed ID: 27203549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitisation of Cancer Cells to MLN8237, an Aurora-A Inhibitor, by YAP/TAZ Inactivation.
    Oku Y; Nishiya N; Sugiyama S; Sato H; Uehara Y
    Anticancer Res; 2018 Jun; 38(6):3471-3476. PubMed ID: 29848699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP and TAZ modulate cell phenotype in a subset of small cell lung cancer.
    Horie M; Saito A; Ohshima M; Suzuki HI; Nagase T
    Cancer Sci; 2016 Dec; 107(12):1755-1766. PubMed ID: 27627196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of TAZ/YAP promotes the progression of malignant melanoma and affects the postoperative survival of patients.
    Feng Q; Guo P; Kang S; Zhao F
    Pharmazie; 2018 Nov; 73(11):662-665. PubMed ID: 30396386
    [No Abstract]   [Full Text] [Related]  

  • 15. The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications.
    Maugeri-Saccà M; Barba M; Pizzuti L; Vici P; Di Lauro L; Dattilo R; Vitale I; Bartucci M; Mottolese M; De Maria R
    Expert Rev Mol Med; 2015 Jul; 17():e14. PubMed ID: 26136233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actin like-6A promotes glioma progression through stabilization of transcriptional regulators YAP/TAZ.
    Ji J; Xu R; Zhang X; Han M; Xu Y; Wei Y; Ding K; Wang S; Bin Huang ; Chen A; Di Zhang ; Jiang Z; Xu S; Zhang Q; Li W; Ni S; Wang J; Li X
    Cell Death Dis; 2018 May; 9(5):517. PubMed ID: 29725063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel YAP target gene, SGK1, upregulates TAZ activity by blocking GSK3β-mediated TAZ destabilization.
    Yoo G; Kim T; Chung C; Hwang DS; Lim DS
    Biochem Biophys Res Commun; 2017 Aug; 490(3):650-656. PubMed ID: 28634071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
    Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
    Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. YAP/TAZ upstream signals and downstream responses.
    Totaro A; Panciera T; Piccolo S
    Nat Cell Biol; 2018 Aug; 20(8):888-899. PubMed ID: 30050119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Snail/Slug binding interactions with YAP/TAZ control skeletal stem cell self-renewal and differentiation.
    Tang Y; Feinberg T; Keller ET; Li XY; Weiss SJ
    Nat Cell Biol; 2016 Sep; 18(9):917-29. PubMed ID: 27479603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.